FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMC 1914562)

Published in Am J Hum Genet on March 01, 1996

Authors

G A Meyers1, D Day, R Goldberg, D L Daentl, K A Przylepa, L J Abrams, J M Graham, M Feingold, J B Moeschler, E Rawnsley, A F Scott, E W Jabs

Author Affiliations

1: Center for Medical Genetics, Johns Hopkins Hospital, Baltimore, MD 21287-3914, USA.

Articles citing this

MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res (2010) 9.80

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J (1999) 3.79

A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22

Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet (2005) 2.17

FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev (2005) 1.99

Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet (2000) 1.85

The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol (2015) 1.82

Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning. Genes Dev (1998) 1.79

Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci U S A (1998) 1.64

Molecular genetics of craniosynostotic syndromes. Graefes Arch Clin Exp Ophthalmol (1997) 1.04

Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling. Am J Hum Genet (2012) 1.02

Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? J Med Genet (2000) 1.01

Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers. Apoptosis (2013) 0.89

Novel FGFR2 deletion in a patient with Beare-Stevenson-like syndrome. Am J Med Genet A (2009) 0.88

Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells. Mol Cell Biol (1997) 0.84

Genetics of craniosynostosis: review of the literature. J Med Life (2010) 0.83

The Fgfr2 W290R mouse model of Crouzon syndrome. Childs Nerv Syst (2012) 0.83

Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly. J Med Genet (1998) 0.81

A model for the pharmacological treatment of crouzon syndrome. Neurosurgery (2006) 0.80

Understanding craniosynostosis as a growth disorder. Wiley Interdiscip Rev Dev Biol (2016) 0.79

Ala344Pro mutation in the FGFR2 gene and related clinical findings in one Chinese family with Crouzon syndrome. Mol Vis (2012) 0.79

Clues from Crouzon: Insights into the potential role of growth factors in the pathogenesis of myelinated retinal nerve fibers. J Curr Ophthalmol (2016) 0.77

Pfeiffer syndrome: clinical and genetic findings in five Brazilian families. Med Oral Patol Oral Cir Bucal (2015) 0.76

Unique modulation of cadherin expression pattern during posterior frontal cranial suture development and closure. Cells Tissues Organs (2009) 0.76

Mutational identification of fibroblast growth factor receptor 1 and fibroblast growth factor receptor 2 genes in craniosynostosis in Indian population. Indian J Hum Genet (2013) 0.75

Molecular analysis of FGFR 2 and associated clinical observations in two Chinese families with Crouzon syndrome. Mol Med Rep (2016) 0.75

A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization. Sci Rep (2015) 0.75

Actual concepts in scaphocephaly : (an experience of 98 cases). J Med Life (2011) 0.75

Involvement of Fibroblast Growth Factors and Their Receptors in Epididymo-Testicular Descent and Maldescent. Mol Syndromol (2016) 0.75

A de novo missense mutation of FGFR2 causes facial dysplasia syndrome in Holstein cattle. BMC Genet (2017) 0.75

Articles cited by this

Fluorescence detection in automated DNA sequence analysis. Nature (1986) 12.53

Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet (1995) 4.01

A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet (1994) 2.85

Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet (1994) 2.83

Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet (1995) 2.49

Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet (1994) 2.06

Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet (1995) 1.85

FGFR2 mutations in Pfeiffer syndrome. Nat Genet (1995) 1.82

Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr (1976) 1.77

Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet (1995) 1.76

Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum Mol Genet (1995) 1.45

Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet (1995) 1.31

Effect on splicing of a silent FGFR2 mutation in Crouzon syndrome. Nat Genet (1995) 1.28

Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet (1995) 1.25

Articles by these authors

Online Mendelian Inheritance in Man (OMIM). Hum Mutat (2000) 7.54

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet (2001) 6.96

Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01

Reverse transcriptase encoded by a human transposable element. Science (1991) 5.86

Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A (1995) 5.62

Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr (1981) 5.35

Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology (1997) 4.86

A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet (1999) 4.14

Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet (1992) 4.07

Isolation of an active human transposable element. Science (1991) 3.99

Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet (1997) 3.70

CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) (1998) 3.33

PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet (1999) 3.22

Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet (1989) 3.22

Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis (1994) 3.12

Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA (1990) 3.11

Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet (1992) 3.10

Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02

DNA restriction endonuclease analysis for localization of human beta- and delta-globin genes on chromosome 11. Proc Natl Acad Sci U S A (1979) 3.02

Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88

Emerging quinolone resistance in campylobacters. Lancet (1992) 2.86

Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet (1997) 2.85

Quantitative calibration and use of DNA probes for investigating chromosome abnormalities in the Prader-Willi syndrome. Am J Med Genet (1989) 2.83

Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology (2011) 2.64

Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial. J Gen Intern Med (1991) 2.56

Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics (1992) 2.55

Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet (1995) 2.51

Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids. Am J Hum Genet (1986) 2.45

Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med (2000) 2.42

Metabolic responses to selective beta-adrenergic stimulation in man. Postgrad Med J (1975) 2.38

Evolution of the beta-globin gene cluster in man and the primates. J Mol Biol (1981) 2.31

Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol (2001) 2.31

GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet (1997) 2.28

Directly observed therapy in an inner city hospital. Int J Tuberc Lung Dis (1998) 2.25

Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat (1999) 2.24

AT-rich palindromes mediate the constitutional t(11;22) translocation. Am J Hum Genet (2000) 2.21

Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet (1993) 2.21

Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem (1994) 2.20

Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am J Hum Genet (1995) 2.19

Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19

Clinical and molecular studies in full trisomy 22: further delineation of the phenotype and review of the literature. Am J Med Genet (1995) 2.15

Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull (2000) 2.11

Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. Science (1985) 2.09

Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet (1994) 2.06

Television violence--reactions from physicians, advertisers and the networks. N Engl J Med (1977) 2.02

Restriction fragment length polymorphisms within proximal 15q and their use in molecular cytogenetics and the Prader-Willi syndrome. Am J Med Genet (1989) 2.00

A case of trisomy 9. J Med Genet (1973) 1.99

Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.95

SOME EFFECTS ON PISUM SATIVUM OF A LACK OF CALCIUM IN THE NUTRIENT SOLUTION. Science (1928) 1.92

Normal values for selected physical parameters: an aid to syndrome delineation. Birth Defects Orig Artic Ser (1974) 1.91

Acute otitis media in children. Serologic studies and attempts to isolate viruses and mycoplasmas from aspirated middle-ear fluids. N Engl J Med (1967) 1.87

Characterization of a cloned DNA sequence that is present at centromeres of all human autosomes and the X chromosome and shows polymorphic variation. Proc Natl Acad Sci U S A (1984) 1.86

Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet (2000) 1.85

Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet (1995) 1.85

Femoral hypoplasia--unusual facies syndrome. J Pediatr (1975) 1.84

The location of proteins labeled by the 125I-lactoperoxidase system in the NIL 8 hamster fibroblast. Cell (1975) 1.84

Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet (2001) 1.84

Angelman syndrome: three molecular classes identified with chromosome 15q11q13-specific DNA markers. Am J Hum Genet (1990) 1.83

beta-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site. Proc Natl Acad Sci U S A (1984) 1.81

Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. Proc Natl Acad Sci U S A (2006) 1.80

A unique de novo interstitial deletion del(17)(q21.3q23) in a phenotypically abnormal infant. Clin Genet (1992) 1.76

Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element. Proc Natl Acad Sci U S A (1993) 1.76

A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy--a systematic review and meta-analysis of randomized trials. Br J Anaesth (2006) 1.75

Diagnostic ultrasound: effects on the DNA and growth patterns of animal cells. Radiology (1979) 1.75

The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA (1991) 1.74

The Saethre-Chotzen syndrome. Birth Defects Orig Artic Ser (1975) 1.72

American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology (1998) 1.71

Prenatal diagnosis of sickle cell anemia by restriction and endonuclease analysis: HindIII polymorphisms in gamma-globin genes extend test applicability. Proc Natl Acad Sci U S A (1980) 1.71

Senile External Exudative Macular Retinitis with Remarks on Similar Tumor Formation in a Case of Angioid Streaks. Trans Am Ophthalmol Soc (1924) 1.71

Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry (1996) 1.71

The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J Virol (1991) 1.65

Health characteristics and medical service use patterns of sheltered homeless and low-income housed mothers. J Gen Intern Med (1998) 1.62

Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am J Hum Genet (1991) 1.62

The incorporation of steroid molecules into lecithin sols, beta-lipoproteins and cellular membranes. Eur J Biochem (1968) 1.61

Ampicillin in the treatment of Listeria monocytogenes meningitis. Lancet (1968) 1.57

Traffic particles and occurrence of acute myocardial infarction: a case-control analysis. Occup Environ Med (2009) 1.57

Jarcho-Levin syndrome: four new cases and classification of subtypes. Am J Med Genet (1991) 1.55

RecA polymerization on double-stranded DNA by using single-molecule manipulation: the role of ATP hydrolysis. Proc Natl Acad Sci U S A (1999) 1.54

I-cell disease: a clinical picture. J Pediatr (1971) 1.54

Radiological malformations of the ear in Pendred syndrome. Clin Radiol (1998) 1.52

De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet (1999) 1.50

Bayesian analysis for a single 2 x 2 table. Stat Med (1997) 1.50

Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut (2000) 1.50

Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet (1996) 1.49

Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat Genet (1996) 1.49

Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients. Johns Hopkins Med J (1975) 1.48

Down syndrome--an update and review for the primary pediatrician. Clin Pediatr (Phila) (1991) 1.48

Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. Arch Dis Child Fetal Neonatal Ed (2005) 1.48

Carcinoma of the Thyroid. Proc R Soc Med (1947) 1.47

Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. J Med Genet (2005) 1.46

Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumor cells. EMBO J (1985) 1.46

Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry (2001) 1.46

Smoking cessation and severity of disease: the Coronary Artery Smoking Intervention Study. Health Psychol (1992) 1.46

Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. J Clin Invest (1989) 1.45

TCOF1 gene encodes a putative nucleolar phosphoprotein that exhibits mutations in Treacher Collins Syndrome throughout its coding region. Proc Natl Acad Sci U S A (1997) 1.44

Multiple adnexal tumors and a parotid basal cell adenoma. J Am Acad Dermatol (1991) 1.44

Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am J Med Genet (1995) 1.43

Retinopathy of prematurity. Diagnosis, severity, and natural history. Ophthalmology (1987) 1.43

High-risk obstetric patients. Maternal morbidity after cesareans. J Reprod Med (1997) 1.43